TEVA PHARMACEUTICAL-SP ADR (TEVA) Stock Earnings Estimates
NYSE:TEVA • US8816242098
33.935 USD
+0.03 (+0.07%)
Last: Feb 24, 2026, 12:56 PM
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|
| Revenue YoY % growth | 15.846B 6.17% | 16.544B 4.40% | 17.258B 4.32% | 17.366B 0.63% | 17.656B 1.67% | |
| EBITDA YoY % growth | 4.693B 4.45% | 4.647B -0.98% | 4.372B -5.92% | 5.268B 20.49% | 5.674B 7.71% | |
| EBIT YoY % growth | 3.54B 11.15% | 3.588B 1.36% | 3.37B -6.08% | 4.536B 34.60% | 4.952B 9.17% | |
| Operating Margin | 22.34% | 21.69% | 19.53% | 26.12% | 28.05% | |
| EPS YoY % growth | 2.61 1.19% | 2.54 -2.73% | 2.98 17.27% | 2.84 -4.58% | 3.20 12.64% |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|
| EPS Q2Q % growth | 0.50 -6.14% | 0.66 -2.64% | 0.77 -3.23% | 0.78 -20.31% |
| Revenue Q2Q % growth | 3.754B -3.52% | 4.273B 2.32% | 4.505B 0.56% | 4.46B -5.33% |
| EBITDA Q2Q % growth | 1.054B 2.43% | N/A | N/A | N/A |
| EBIT Q2Q % growth | 1.041B 32.61% | 1.115B 17.62% | 1.258B 12.32% | 1.276B 121.14% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2025 Q2Q % growth | 0.98 35.21% | 0.71 | 0.27 | 38.54% |
| Q3 2025 Q2Q % growth | 0.80 13.04% | 0.68 | 0.11 | 16.51% |
| Q2 2025 Q2Q % growth | 0.67 8.20% | 0.64 | 0.03 | 4.65% |
| Q1 2025 Q2Q % growth | 0.53 8.33% | 0.50 | 0.03 | 5.84% |
| Q4 2024 Q2Q % growth | 0.72 -29.00% | 0.71 | 0.01 | 2.01% |
| Q3 2024 Q2Q % growth | 0.70 15.00% | 0.68 | 0.02 | 3.02% |
| Q2 2024 Q2Q % growth | 0.62 8.93% | 0.59 | 0.03 | 4.92% |
| Q1 2024 Q2Q % growth | 0.49 20.00% | 0.54 | -0.05 | -8.98% |
| Q4 2023 Q2Q % growth | 1.02 40.85% | 0.79 | 0.23 | 28.49% |
| Q3 2023 Q2Q % growth | 0.61 1.69% | 0.62 | -0.01 | -1.59% |
| Q2 2023 Q2Q % growth | 0.57 -17.65% | 0.55 | 0.02 | 3.64% |
| Q1 2023 Q2Q % growth | 0.41 -27.27% | 0.59 | -0.18 | -30.51% |
| Q4 2022 Q2Q % growth | 0.72 -7.79% | 0.79 | -0.07 | -8.41% |
| Q3 2022 Q2Q % growth | 0.60 | 0.65 | -0.05 | -7.45% |
| Q2 2022 Q2Q % growth | 0.69 15.25% | 0.62 | 0.07 | 11.11% |
| Q1 2022 Q2Q % growth | 0.56 -12.70% | 0.63 | -0.07 | -11.60% |
| Q4 2021 Q2Q % growth | 0.79 13.24% | 0.75 | 0.04 | 4.85% |
| Q3 2021 Q2Q % growth | 0.60 1.72% | 0.67 | -0.06 | -9.62% |
| Q2 2021 Q2Q % growth | 0.60 7.27% | 0.66 | -0.05 | -8.19% |
| Q1 2021 Q2Q % growth | 0.64 | 0.63 | 0.01 | 1.25% |
| Q4 2020 Q2Q % growth | 0.69 | 0.66 | 0.04 | 5.82% |
| Q3 2020 Q2Q % growth | 0.59 | 0.61 | -0.02 | -3.62% |
| Q2 2020 Q2Q % growth | 0.56 | 0.62 | -0.06 | -10.13% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2025 Q2Q % growth | 4.711B 11.40% | 4.455B | 256M | 5.75% |
| Q3 2025 Q2Q % growth | 4.48B 3.42% | 4.44B | 40M | 0.90% |
| Q2 2025 Q2Q % growth | 4.176B 0.29% | 4.385B | -209M | -4.77% |
| Q1 2025 Q2Q % growth | 3.891B 1.89% | 4.082B | -191M | -4.68% |
| Q4 2024 Q2Q % growth | 4.229B -5.12% | 4.203B | 26M | 0.62% |
| Q3 2024 Q2Q % growth | 4.332B 12.52% | 4.221B | 111M | 2.63% |
| Q2 2024 Q2Q % growth | 4.164B 7.49% | 4.13B | 34M | 0.82% |
| Q1 2024 Q2Q % growth | 3.819B 4.15% | 3.834B | -15M | -0.39% |
| Q4 2023 Q2Q % growth | 4.457B 14.75% | 4.074B | 383M | 9.40% |
| Q3 2023 Q2Q % growth | 3.85B 7.09% | 3.794B | 56M | 1.48% |
| Q2 2023 Q2Q % growth | 3.874B 2.32% | 3.764B | 110M | 2.92% |
| Q1 2023 Q2Q % growth | 3.667B 0.16% | 3.717B | -50M | -1.35% |
| Q4 2022 Q2Q % growth | 3.884B -5.27% | 3.98B | -96M | -2.41% |
| Q3 2022 Q2Q % growth | 3.595B -7.51% | 3.948B | -353M | -8.94% |
| Q2 2022 Q2Q % growth | 3.786B -3.17% | 3.93B | -144M | -3.66% |
| Q1 2022 Q2Q % growth | 3.661B -8.06% | 3.966B | -305M | -7.69% |
| Q4 2021 Q2Q % growth | 4.1B -7.93% | 4.388B | -288M | -6.56% |
| Q3 2021 Q2Q % growth | 3.887B -2.29% | 4.077B | -190M | -4.66% |
| Q2 2021 Q2Q % growth | 3.91B 1.03% | 4.168B | -258M | -6.19% |
| Q1 2021 Q2Q % growth | 3.982B -8.61% | 4.144B | -162M | -3.91% |
| Q4 2020 Q2Q % growth | 4.453B | 4.428B | 25M | 0.56% |
| Q3 2020 Q2Q % growth | 3.978B | 4.129B | -151M | -3.66% |
| Q2 2020 Q2Q % growth | 3.87B | 4.194B | -324M | -7.73% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -15.03% | -9.02% | 0.51% | -0.38% |
| Revenue | -8.13% | -5.8% | 0% | 0.42% |